AesculaTech
AesculaTech, based in Los Angeles, specializes in medical devices for eye care, notably its innovative product Humidifeye, designed to treat dry eye disease with a unique temperature-sensitive gel.
About AesculaTech
AesculaTech is a healthcare company based in Los Angeles, CA, USA. It focuses on developing advanced medical devices designed for the treatment of medical conditions. The company was founded in 2016 by researchers from the University of Southern California. It operates within the healthcare and medical devices sub-industry and was part of the Y-Combinator W18 batch. The company's innovative solutions are primarily targeted towards improving patient outcomes in the United States and North America.
Founding and Team
AesculaTech was founded in 2016 by researchers from the University of Southern California. The founding team has leveraged their research background to create cutting-edge medical solutions. Based in Los Angeles, CA, AesculaTech employs a small, focused team of six individuals who contribute to its innovative approach in the healthcare sector. Their collective expertise drives the company's mission to improve medical treatments through advanced technology and rigorous research.
Product: Humidifeye
Humidifeye is AesculaTech’s flagship product specifically designed to treat dry eye disease. This temperature-sensitive gel is delivered directly to the tear duct using a sterile, disposable autoinjector. With a single press of a button, Humidifeye aims to provide immediate and sustained symptom relief. This product has been validated through evaluations with over 20 key opinion leaders and in a blinded survey involving 178 optometrists and ophthalmologists. Additionally, a study involving 44 eyes confirmed improvements in signs, symptoms, and patient quality of life.
Market Validation
Extensive research executed by Market Scope has validated the potential market for Humidifeye. The findings indicate a significant demand for effective treatments for dry eye disease, positioning Humidifeye as a viable solution within this market. Conservative financial models project that AesculaTech could achieve over $100 million in revenue by the third year of Humidifeye’s market presence. This forecast underscores both the innovation behind Humidifeye and its substantial commercial potential.
Y-Combinator W18 Batch
AesculaTech was part of the Winter 2018 (W18) batch of Y-Combinator, a renowned startup accelerator that supports early-stage companies with funding, mentorship, and resources. Being part of this program provided AesculaTech with the opportunity to refine their business model, gain strategic connections, and access critical initial funding. This experience helped lay a strong foundation for the company’s subsequent development and its product, Humidifeye.